Endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 15095227.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Clinical management of infective endocarditis (IE) is expected to become more difficult with the emergence of Staphylococcus aureus with reduced susceptibility to vancomycin (SARV) in the United States and worldwide. We report the strain characterization and treatment of a patient with SARV IE.
Medical subject headings
- Anti-Bacterial Agents
- Endocarditis, Bacterial
- Staphylococcus aureus
- Vancomycin
- Vancomycin Resistance